KLA Corporation (KLAC): analysis and signal as of September 7, 2026
In short
The MODERATE signal on KLA Corporation rests on a solid Q4 FY2026 publication expected on 07/09/2026 with revenue growth of 32 % year-over-year. The rating reflects a combination of an attractive valuation profile (PEG 0.59) and a macro backdrop supportive of semiconductors, tempered by a complacent risk regime and a hidden concentration with ASML.
- Current signal
- moderate (vote 3/3)
- Deterministic score
- +3.0 → signal expected by the scale : moderate (September 10, 2026)
- Layers
- fundamentals : positive, price : positive, risks : positive
Triggered rules
| Rule | Weight |
|---|---|
| favors a high and durable return on invested capital (ROIC), a marker of a lasting moat | +2.0 |
| penalizes a PEG above 2, the anticipated growth is overpaid (overvalued fast grower) | -1.5 |
| favors robust fundamental health (high Piotroski F-Score) | +1.5 |
| penalizes direct holding of US securities in a CTO (US estate tax at death), favors a UCITS ETF domiciled in IE | -1.0 |
| favors high gross profitability (gross profit / assets), a robust predictor of returns | +1.0 |
| moderately favors an asset with robust operating profitability (RMW factor), cross-check with accounting quality (possible manipulation) | +0.5 |
| moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger | +0.5 |
Thesis
KLA Corporation, a quality process control equipment supplier, presents an attractive valuation profile with a PEG of 0.59 and benefits from an expansive macro backdrop supportive of semiconductors and artificial intelligence, with a bullish contextual weighting of 0.58. The share price at 185.60 USD sits between the 50-day and 200-day moving averages, which points to a lack of clear directional impulse in the near term. The release of the Q4 FY2026 publication scheduled for 07/09/2026, with a T5 guidance of 3.0 Bn$ in revenue, constitutes the catalyst likely to validate the bullish dynamic or to confirm a consolidation phase.
Bull case
The Q4 FY2026 publication expected on 07/09/2026 highlights revenue of 2.906 Bn$ advancing 32 % year-over-year, a non-GAAP gross margin of 56.4 %, and a T5 guidance of 3.0 Bn$ in revenue, illustrating the strength of the operating model. The macro backdrop supports the semiconductors and artificial intelligence segment with a bullish weighting of 0.58. Specialized semiconductor ETFs recorded 46 Bn$ of net inflows in 2026, a historical record, reflecting strong appetite from flows for the segment. The bullish scenario incorporates a mean target of 234 USD, up 26 % versus the reference price, with an associated probability of 40 %.
Bear case
The Cboe risk regime remains in complacency, materialized by a VIX9D/VIX3M slope at -32 % and a put/call ratio at 0.76, a configuration historically associated with reversal phases. The hidden correlation with ASML reaches 0.66 within a robustness group, which amplifies aggregate volatility by approximately 30 %. The beta of 2.80 against the S&P 500 and the sensitivity to the 10-2 year slope at +0.41 points expose the stock to a marked valuation revision risk in the event of monetary tightening. The bearish scenario, estimated at 20 % probability, envisions a maximum loss of 15 % toward 158 USD, with the 200-day moving average standing at 154.80 USD.
Scenarios
The bullish scenario, with a 40 % probability, targets 234 USD corresponding to the analyst average, a 26 % advance. The central scenario, weighted at 40 %, projects consolidation of the price within a range between 170 and 200 USD. The bearish scenario, assigned a 20 % probability, projects a maximum loss of 15 % toward 158 USD, a level to be compared with the 200-day moving average at 154.80 USD.
Risks
The main identified risks concern a reversal of the risk regime currently in complacency, the hidden concentration with ASML which raises aggregate volatility, the elevated beta of 2.80 which amplifies moves against the S&P 500, and the sensitivity to the 10-2 year rate slope at +0.41 points. An adverse evolution of any of these parameters could invalidate the bullish thesis carried by valuation and sector flows.
Market positioning (short sellers)
- Short interest / shares outstanding
- 2.26 %
- Days to cover
- 3.36
- Settlement date
- 2026-08-31
- Source
- FINRA (disseminated on 2026-09-12)
Upcoming catalysts
| Date | Description |
|---|---|
| Q4 FY2026 publication expected early November, update on 2 nm yield |
Signal history (last 12 months)
| Date | Signal | New fact |
|---|---|---|
| moderate (3/3) | Personal analysis, not advice. | |
| moderate (3/3) | First verdict recorded on this stock. No new verified numerical data came in today to change the signal. Personal analysis, not advice. |
Frequently asked questions
What to take away from the PEG of 0.59 on KLA Corporation?
The PEG of 0.59 reflects attractive valuation relative to expected growth, consistent with the 32 % year-over-year revenue expansion published for Q4 FY2026. This level nevertheless needs to be compared against risk parameters, notably the beta of 2.80 and the concentration with ASML.
What is the contribution of the Q4 FY2026 revenue expected on 07/09/2026?
The Q4 FY2026 publication highlights revenue of 2.906 Bn$ up 32 % year-over-year and a non-GAAP gross margin of 56.4 %. The T5 guidance of 3.0 Bn$ in revenue materializes the growth trajectory driven by the artificial intelligence and semiconductor segment.
Why does the concentration with ASML constitute a risk factor?
The correlation of 0.66 with ASML within a robustness group raises aggregate volatility by approximately 30 % in the event of simultaneous exposure. This factor is amplified by the beta of 2.80 and the sensitivity to the 10-2 year slope at +0.41 points, which penalizes the overall risk profile.
What does the Cboe risk regime in complacency mean?
The VIX9D/VIX3M slope at -32 % and the put/call ratio at 0.76 characterize a risk regime in complacency, historically conducive to reversals. This configuration calls for caution in the interpretation of bullish signals carried by valuation and sector flows.
Sources
The official filings below are the issuer's own, matched to this stock by its identifier (LEI, CIK or ISIN). The figures quoted above come from an automated arbitration: they have not been re-checked one by one.
- — 8.01 Other Events; 9.01 Financial Statements and Exhibits (SEC · 8-K)
- — 10-K (SEC · 10-K)
- — 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits (SEC · 8-K)
- — 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits (SEC · 8-K)
- — 8.01 Other Events; 9.01 Financial Statements and Exhibits (SEC · 8-K)
Automated AI analysis: limitations and transparency
- This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
- Tool and analysis: QDNA, Aurélien Ambert.
- Analysis (arbitration) completed on September 7, 2026; this page was completed on September 7, 2026 at 07:20 (UTC).
- Interests: no position in the stock analysed (KLAC) is recorded in the data consulted on (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
- This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
- Methodology: analysis chain, score formula and scale described on the public methodology page.
- Analysis horizon: 2035.
See also
- Neighbouring stock in the same sector: Apple Inc. (AAPL)
- All analysed stocks
- Public methodology